EUR 8.0
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 3.54 Million EUR | -62.1% |
2022 | 9.21 Million EUR | -44.68% |
2021 | 16.65 Million EUR | 23.72% |
2020 | 13.46 Million EUR | 209.54% |
2019 | 4.35 Million EUR | 32.46% |
2018 | 3.28 Million EUR | -5.24% |
2017 | 3.46 Million EUR | -10.84% |
2016 | 3.88 Million EUR | -2.67% |
2015 | 3.99 Million EUR | 57.53% |
2014 | 2.53 Million EUR | 35.04% |
2013 | 1.87 Million EUR | 27.2% |
2012 | 1.47 Million EUR | -19.68% |
2011 | 1.83 Million EUR | 96.32% |
2010 | 936.03 Thousand EUR | 63.75% |
2009 | 571.64 Thousand EUR | -8.95% |
2008 | 627.82 Thousand EUR | 87.05% |
2007 | 335.65 Thousand EUR | -69.41% |
2006 | 1.09 Million EUR | 129.36% |
2005 | 478.46 Thousand EUR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 2.15 Million EUR | 0.0% |
2023 FY | 3.49 Million EUR | -62.1% |
2023 Q4 | 1.66 Million EUR | 0.0% |
2023 Q2 | 1.88 Million EUR | 0.0% |
2022 Q2 | 4.26 Million EUR | 0.0% |
2022 FY | 9.21 Million EUR | -44.68% |
2022 Q4 | 6.3 Million EUR | 0.0% |
2021 FY | 16.65 Million EUR | 23.72% |
2021 Q4 | 6.95 Million EUR | 0.0% |
2021 Q2 | 9.73 Million EUR | 0.0% |
2020 Q4 | 9.99 Million EUR | 0.0% |
2020 Q2 | 3.83 Million EUR | 0.0% |
2020 FY | 13.46 Million EUR | 209.54% |
2019 FY | 4.35 Million EUR | 32.46% |
2019 Q4 | 2.58 Million EUR | 0.0% |
2019 Q2 | 2 Million EUR | 0.0% |
2018 Q4 | 2.53 Million EUR | 0.0% |
2018 FY | 3.28 Million EUR | -5.24% |
2018 Q2 | 752.64 Thousand EUR | 0.0% |
2017 FY | 3.46 Million EUR | -10.84% |
2017 Q4 | 2.11 Million EUR | 0.0% |
2017 Q2 | 1.35 Million EUR | 0.0% |
2016 Q4 | 2.46 Million EUR | 0.0% |
2016 Q2 | 1.42 Million EUR | 0.0% |
2016 FY | 3.88 Million EUR | -2.67% |
2015 Q2 | 1.34 Million EUR | 0.0% |
2015 FY | 3.99 Million EUR | 57.53% |
2015 Q4 | 2.64 Million EUR | 0.0% |
2014 Q2 | 974.42 Thousand EUR | 0.0% |
2014 Q4 | 1.56 Million EUR | 0.0% |
2014 FY | 2.53 Million EUR | 35.04% |
2013 Q2 | 262.33 Thousand EUR | 0.0% |
2013 Q4 | 1.61 Million EUR | 0.0% |
2013 FY | 1.87 Million EUR | 27.2% |
2012 Q3 | 418.4 Thousand EUR | 0.0% |
2012 FY | 1.47 Million EUR | -19.68% |
2012 Q4 | 418.4 Thousand EUR | 0.0% |
2011 FY | 1.83 Million EUR | 96.32% |
2010 FY | 936.03 Thousand EUR | 63.75% |
2010 Q2 | 187.73 Thousand EUR | 0.0% |
2009 Q2 | 162.53 Thousand EUR | 0.0% |
2009 FY | 571.64 Thousand EUR | -8.95% |
2008 Q2 | 157.42 Thousand EUR | 0.0% |
2008 FY | 627.82 Thousand EUR | 87.05% |
2007 FY | 335.65 Thousand EUR | -69.41% |
2006 FY | 1.09 Million EUR | 129.36% |
2005 FY | 478.46 Thousand EUR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
CompuGroup Medical SE & Co. KGaA | 155.16 Million EUR | 97.717% |
MeVis Medical Solutions AG | 6.44 Million EUR | 45.024% |
Nexus AG | 24.76 Million EUR | 85.696% |